+Compare
CRON
Stock ticker:
NASDAQ
AS OF
Loading...
Price
Loading...
Change
Loading...
Capitalization
665.19M

CRON Cronos Group Forecast, Technical & Fundamental Analysis

pharmaceutical, medical marijuana, cannabis

GET INTRADAY SIGNALS
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
A.I.Advisor
a Summary for CRON with price predictions
08:00 PM EDT Jun 01, 2023

Momentum Indicator for CRON turns negative, indicating new downward trend

CRON saw its Momentum Indicator move below the 0 level on June 01, 2023. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 113 similar instances where the indicator turned negative. In of the 113 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for CRON turned negative on May 30, 2023. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at .

CRON moved below its 50-day moving average on May 24, 2023 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CRON declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for CRON entered a downward trend on May 23, 2023. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CRON advanced for three days, in of 220 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

Fear & Greed

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.590) is normal, around the industry mean (42.346). P/E Ratio (0.000) is within average values for comparable stocks, (53.681). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.722). CRON has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.026). P/S Ratio (7.610) is also within normal values, averaging (55.315).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. CRON’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CRON’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are ZOETIS (NYSE:ZTS), Teva Pharmaceutical Industries Limited (NYSE:TEVA), Intra-Cellular Therapies (NASDAQ:ITCI), Elanco Animal Health (NYSE:ELAN), Bausch Health Companies (NYSE:BHC), Tilray Brands (NASDAQ:TLRY), Avadel Pharmaceuticals plc (NASDAQ:AVDL), Canopy Growth Corp (NASDAQ:CGC), Aurora Cannabis (NASDAQ:ACB), Journey Medical Corp (NASDAQ:DERM).

Industry description

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

Market Cap

The average market capitalization across the Pharmaceuticals: Other Industry is 2.3B. The market cap for tickers in the group ranges from 246 to 79.43B. ZTS holds the highest valuation in this group at 79.43B. The lowest valued company is PEMTF at 246.

High and low price notable news

The average weekly price growth across all stocks in the Pharmaceuticals: Other Industry was 1%. For the same Industry, the average monthly price growth was 5%, and the average quarterly price growth was 25%. INLB experienced the highest price growth at 83%, while ABTI experienced the biggest fall at -59%.

Volume

The average weekly volume growth across all stocks in the Pharmaceuticals: Other Industry was -27%. For the same stocks of the Industry, the average monthly volume growth was -17% and the average quarterly volume growth was -98%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 54
P/E Growth Rating: 72
Price Growth Rating: 65
SMR Rating: 85
Profit Risk Rating: 93
Seasonality Score: -1 (-100 ... +100)
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
A.I. Advisor
published Earnings

CRON is expected to report earnings to fall 33.40% to -3 cents per share on August 10

Cronos Group CRON Stock Earnings Reports
Q2'23
Est.
$-0.03
Q1'23
Missed
by $0.01
Q4'22
Missed
by $0.16
Q3'22
Missed
by $0.04
Q2'22
Beat
by $0.01
The last earnings report on May 09 showed earnings per share of -5 cents, missing the estimate of -3 cents. With 867.10K shares outstanding, the current market capitalization sits at 665.19M.
A.I. Advisor
published General Information

General Information

pharmaceutical, medical marijuana, cannabis

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
111 Peter Street
Phone
+1 416 504-0004
Employees
447
Web
https://www.thecronosgroup.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FCLKX11.820.21
+1.81%
Fidelity® Large Cap Stock K6
BTEFX37.290.55
+1.50%
Boston Trust Equity
AGVDX19.870.20
+1.02%
American Funds Global Insight C
GATCX40.83N/A
N/A
Gabelli Asset C
RSEJX49.99N/A
N/A
Victory RS Small Cap Growth R6

CRON and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRON has been closely correlated with TLRY. These tickers have moved in lockstep 78% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRON jumps, then TLRY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRON
1D Price
Change %
CRON100%
+0.57%
TLRY - CRON
78%
Closely correlated
+1.18%
ACB - CRON
75%
Closely correlated
+2.32%
CGC - CRON
73%
Closely correlated
-1.17%
SNDL - CRON
73%
Closely correlated
+2.07%
OGI - CRON
71%
Closely correlated
+0.67%
More

Groups containing CRON

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRON
1D Price
Change %
CRON100%
+0.57%
CRON
(undefined stocks)
87%
Closely correlated
+0.94%
marijuana cannabis
(undefined stocks)
85%
Closely correlated
+0.99%
pharmaceuticals
(undefined stocks)
47%
Loosely correlated
+1.61%
north america
(undefined stocks)
46%
Loosely correlated
+1.96%
Pharmaceuticals: Other
(undefined stocks)
3%
Poorly correlated
+1.33%
More